CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
CompuGroup Medical Dividend Announcement
• CompuGroup Medical announced a annually dividend of €1.00 per ordinary share which will be made payable on 2024-05-27. Ex dividend date: 2024-05-23
• CompuGroup Medical annual dividend for 2024 was €1.00
• CompuGroup Medical annual dividend for 2023 was €0.50
• CompuGroup Medical's trailing twelve-month (TTM) dividend yield is 6.54%
• CompuGroup Medical's payout ratio for the trailing twelve months (TTM) is 159.22%
• CompuGroup Medical's dividend growth over the last five years (2018-2023) was 7.39% year
• CompuGroup Medical's dividend growth over the last ten years (2013-2023) was 3.63% year
CompuGroup Medical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-23 | €1.00 | annually | 2024-05-27 |
2023-05-18 | €0.50 | annually | 2023-05-23 |
2022-05-20 | €0.50 | annually | 2022-05-24 |
2021-05-20 | €0.50 | annually | 2021-05-25 |
2020-05-14 | €0.50 | annually | 2020-05-18 |
2019-05-16 | €0.50 | annually | 2019-05-20 |
2018-05-16 | €0.35 | annually | 2018-05-18 |
2017-05-11 | €0.35 | annually | 2017-05-15 |
2016-05-19 | €0.35 | annually | 2016-05-19 |
2015-05-21 | €0.35 | annually | 2015-05-21 |
2014-05-15 | €0.35 | annually | 2014-05-15 |
2013-05-16 | €0.35 | annually | 2013-05-16 |
CompuGroup Medical Dividend per year
CompuGroup Medical Dividend growth
CompuGroup Medical Dividend Yield
CompuGroup Medical current trailing twelve-month (TTM) dividend yield is 6.54%. Interested in purchasing CompuGroup Medical stock? Use our calculator to estimate your expected dividend yield:
CompuGroup Medical Financial Ratios
CompuGroup Medical Dividend FAQ
Other factors to consider when evaluating CompuGroup Medical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy CompuGroup Medical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: CompuGroup Medical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, CompuGroup Medical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, CompuGroup Medical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from CompuGroup Medical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: CompuGroup Medical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, CompuGroup Medical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: CompuGroup Medical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of CompuGroup Medical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review CompuGroup Medical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.